|
Located in the heart of Research Triangle Park, North Carolina, Piedmont Research Center provides drug discovery and development services through the design and conduct of in vitro and in vivo studies in rodents. Utilizing models of angiogenesis, cancer, inflammation, rheumatoid arthritis, cardiovascular and metabolic disease, investigational agents are evaluated for pharmacology efficacy and toxicity, as primary, combination and adjuvant therapies. Through our extensive in vitro platform, we provide efficient early compound screening and expanded data results in support of your in-life program. |
 Cerebricon serves the pharmaceutical industry from their Kuopio, Finland site through preclinical in vivo and in vitro neurological disease models of Alzheimer’s (including cognitive and aging components), Parkinson’s and Huntington’s disease, multiple sclerosis, amyotrophic lateral sclerosis, stroke/brain ischemia, spinal cord injury, traumatic brain injury and migraine. Additionally, various in vivo models of psychiatric diseases addressing depression, anxiety and schizophrenia are available for proof of concept studies. Combined on-site MRI imaging of rodents along with behavior and histology analysis in transgenic, surgically and chemically induced rodent models of central nervous system and peripheral nervous system diseases further expands your study results.
|